At a glance
ClinicalIndex Comparison RecordN/ACompleted· 78 enrolled
Drug / intervention
Ultrasound Cardiac Output Monitor and 2 D-Echodevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluating Agreement Between USCOM and 2D-echocardiographic Hemodynamic Measurements in Pediatric Patients
In Brief
An observational study evaluating Ultrasound Cardiac Output Monitor and 2 D-Echo for Hemodynamically Stable and Critical Illness. Completed, enrolled 78 participants across 1 site.
Detailed Summary
The primary objective of this study is to evaluate the agreement between hemodynamic measurements obtained using the Ultrasound Cardiac Output Monitor (USCOM®; USCOM Ltd., Sydney, Australia), and reference standards as determined by 2 Dimensional echocardiography (2D-echo) measurements in a group of hemodynamically stable and unstable pediatric patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHemodynamically Stable, Critical Illness
CountriesCanada
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 2014
Enrollment StartJul 2014
Primary CompletionDec 2015
Study CompletionJan 2016
TodayJul 2026
First PostedMar 11, 2014
Enrollment StartJul 1, 2014
Primary CompletionDec 1, 2015
Study CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 12.3 years ago
Interventions
Ultrasound Cardiac Output Monitor and 2 D-Echodevice
Hemodynamic measurements obtained by 2D-Echo and USCOM will be compared.